OBSRV — Observe Medical ASA Cashflow Statement
0.000.00%
- NOK11.17m
- NOK90.40m
- NOK18.48m
Annual cashflow statement for Observe Medical ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.9 | -26.3 | -50.7 | -60.3 | -127 |
| Depreciation | |||||
| Non-Cash Items | 8.68 | -6.34 | -7.09 | 7.41 | 5.36 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.38 | 7.07 | -4.45 | 14.9 | 8.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.6 | -22.1 | -51.3 | -24.5 | -30.7 |
| Capital Expenditures | -1.24 | -4.89 | -4.93 | -8.02 | -1.84 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -6.84 | 0 | -53.4 | 0.392 | 1.12 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -8.08 | -4.89 | -58.4 | -7.63 | -0.724 |
| Financing Cash Flow Items | — | -0.001 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.2 | 16.1 | 121 | 31.7 | 17.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.5 | -16.1 | 10.8 | 0.036 | -11.7 |